Keywords: Bone, Tumor
Motivation: Clinical applications of APTWI for differentiating benign and malignant bone and soft tissue tumors are scarce.
Goal(s): This work investigated and evaluated the ability of APT and DWI parameters in distinguishing benign from malignant bone and soft tissue tumors.
Approach: MTRasym and ADC values of ninety-six patients in benign and malignant lesions were compared using either the independent samples t-test or Mann-Whitney U test. The ROC curve was used to assess the diagnostic performance in differentiation between benign and malignant tumors.
Results: APTWI combined with DWI showed a significantly improved differentiation between benign and malignant tumors.
Impact: The combination of APTWI and DWI offers valuable insights into changes in cellular proteins and peptides. When MTRasymmax is combined with ADCmin, it yields superior diagnostic performance for distinguishing between malignant and benign bone and soft tissue tumors.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords